Stay updated on Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.

Latest updates to the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This appears to be an administrative version update and does not modify the study details or study-related content.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page's revision tag now shows v3.6.2, replacing the previous v3.6.0 tag.SummaryDifference0.0%

- Check28 days agoChange DetectedThe study page now states No longer looking for participants and adds sections like How to Read a Study Record, Common Questions, and How to Join a Study, improving enrollment information and user guidance. The Intervention/Treatment heading formatting was updated and the Revision version changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check35 days agoChange DetectedThe revision label changed from v3.5.4 to v3.5.5, indicating a new version of the page. This metadata update does not modify the study content or how users interact with the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, reflecting a change in the ClinicalTrials.gov page build rather than the underlying study record.SummaryDifference0.0%

Stay in the know with updates to Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vaccine Therapy with Pembrolizumab in Prostate Cancer Clinical Trial page.